510(k) device
FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)
FindAir Sp. z o.o. · Nebulizer (Direct Patient Interface) (CAF, Class II) · First FDA decision Jun 2, 2026, newest Jun 2, 2026AsthmaCOPD and emphysema
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "FindAir ONE"
MAUDE reports
0
Brand "FindAir ONE", since 2015
PubMed studies
0
Mentioning "FindAir ONE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K260270 · Decided Jun 2, 2026 · 125 days after receipt
Device type: Nebulizer (Direct Patient Interface) (CAF) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- NebulizersLocal determinationIn effectL33370CGS Administrators, LLCUpdated Feb 12, 2026
- NebulizersProposed local determinationProposedDL33370CGS Administrators, LLCUpdated Aug 22, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "FindAir ONE", any status and sponsor, newest update first.
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT06902766 · 50 participants (planned) · Start Nov 25, 2025 · Primary completion Jul 2027
Device: Active telemonitoring using real-time data from digital inhalers. · For: Pediatric Asthma
Sites: Paris, France
- Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary DiseasePivotal-lookingRecruiting
Franciscus GasthuisAcademic, hospital or other
NCT05495698 · 300 participants (planned) · Start Dec 13, 2022 · Primary completion Dec 2026
Device: E-health application: Curavista app & FindAir e-device · For: Copd; Adherence, Medication
Sites: Rotterdam, Netherlands
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "FindAir ONE", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code CAF
2,410 reports: 2,117 malfunction, 199 injury, 27 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "FindAir ONE"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code CAF.
- Propeller Sensor for SymbicortReciprocal Labs Corporation · 510(k) 2020
- Hailie Sensor NF0110Adherium (Nz), Ltd. · 510(k) 2023
- eRapid with eTrack SystemPari Respiratory Equipment, Inc. · 510(k) 2025
- Ultrasonic Mesh NebulizerFoshan Gaunying Electronics Co., Ltd. · 510(k) 2014
- Portable NebulizerMicrobase Technology Corporation · 510(k) 2018
- SmartTouchAdherium (Nz), Ltd. · 510(k) 2018
- Comp A-I-ROmron Healthcare, Inc. · 510(k) 2014
- Ultrasonic Nebulizer (Mesh Type)K-Jump Health Co., Ltd. · 510(k) 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.